Concepedia

Michelle Robeson

MR

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2013

Affiliations

Gilead Sciences (United States)(Current)

Michelle Robeson is an author at Gilead Sciences (United States) specializing in clinical pharmacology, pharmacology, and pharmacokinetics.

Publications per year

2013–2016

5

Publications

5

Clinical drug interaction profile of idelalisib in healthy subjects

Feng Jin, Michelle Robeson, Huafeng Zhou et al. · The Journal of Clinical Pharmacology · 2015 · 48 citations

, , +17

The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment

Feng Jin, Michelle Robeson, Huafeng Zhou et al. · The Journal of Clinical Pharmacology · 2015 · 28 citations

, , +13

Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers

Srini Ramanathan, Julie A. Di Paolo, Feng Jin et al. · Clinical Drug Investigation · 2016 · 25 citations · Full text

, , +11

Pharmacokinetics, Metabolism and Excretion Of Idelalisib

Feng Jin, Michelle Robeson, Huafeng Zhou et al. · Blood · 2013 · 24 citations

, , +10

The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment

Michelle Robeson, Hongjun Zhou, Grace Hisoire et al. · Cancer Chemotherapy and Pharmacology · 2015 · 17 citations

, , +12

1–5 of 5